Pandemic disrupted the entire world and affected many industries.
Get detailed COVID-19 impact analysis on the Wound Care MarketRequest Sample
The global wound care market is anticipated to reach USD XX,XXX.X million by 2030 from USD XX,XXX.X million in 2022, at a CAGR of X.X% during the forecast period.
The global wound care market is expected to be driven by the rising prevalence of chronic diseases around the world, the increasing number of surgical procedures, and advancements in wound care devices.
The COVID-19 epidemic harmed the distribution and sales of wound care products globally. Since, the epidemic compelled the suspension of all public and private transportation, the number of people needing active medical attention has significantly decreased. The market is gradually picking up speed with a notable growth rate in the post-pandemic era.
On the basis of product, the market is segmented into advanced wound care products, traditional wound care products, surgical wound care products, negative pressure wound therapy, and bioactives. The advanced wound care products segment is expected to dominate the market in the forecast period of 2022-2030.
On the basis of wound type, the market is segmented into burns and surgical & open wounds, pressure ulcers, diabetic foot ulcers, venous leg ulcers, and traumatic wounds. The diabetic foot ulcers segment is expected to experience the fastest CAGR during the forecast period of 2022-2030.
On the basis of application, the market is bifurcated into chronic wounds and acute wounds. The chronic wounds segment is expected to grow at the fastest CAGR in the forecast period of 2022-2030.
On the basis of end-use, the market is segmented into hospitals, ambulatory surgery centers, home care settings, and others. In 2021, hospitals and clinics remained the largest segment of the wound care market. The increase use of technologically advanced wound care products drove the growth of this segment.
Key Companies Covered
Some of the companies profiled in the report includes 3M Company, ACell, Advancis Medical, Applied Biologics, B. Braun, Baxter International, Bioventus, Cardinal Health, Coloplast A/S, Convatec Group, Covalon Technologies Ltd., DermaRite Industries, LLC, DeRoyal Industries, Ethicon, Inc, Haromed Ltd, Integra LifeSciences, Kerecis, Lohmann & Rauscher, Medela, Medline Industries, LP, Medtronic Plc, Mil Laboratories Pvt Ltd, MIMEDX, Mölnlycke Health Care AB, Organogenesis Holdings Inc., Pensar Medical, Skye Biologics Holdings, LLC, Smith & Nephew plc, Talley Group, Tissuetech, Ventris Medical, LLC, Welcare Industries S.P.A., Wuhan VSD Medical Technology Co., Ltd, and Zimmer Biomet.
Powered by Froala Editor
Custom Research Requirement? Questions to ask?Get in touch
Custom Research requirement.